Giuseppe Ciaramella, President at Beam Therapeutics Inc. (BEAM), sold 11,810 shares at $24.58 ($290K) on 2026-04-01, disclosed to the SEC on 2026-04-06.
Scheduled sale ($290k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-04-03 | $291K | — | Filing → |